🎉 M&A multiples are live!
Check it out!

Star Lake Bioscience Valuation Multiples

Discover revenue and EBITDA valuation multiples for Star Lake Bioscience and similar public comparables like Vivoryon Therapeutics, Pharming, and Julphar.

Star Lake Bioscience Overview

About Star Lake Bioscience

Star Lake Bioscience Co Inc is a China-based Pharmaceutical manufacturer. The company is mainly engaged in the research, development, production, and sales of chemical raw materials and pharmaceutical intermediates. Products offered by the company include proline, guanosine, adenosine, adenine, adefovir dipivoxil, memantine hydrochloride, Proline, threonine, lysine, among others. Its products are used in food processing, feed processing, and pharmaceutical manufacturing. Star Lake sells its products through direct sales and distributors in China and overseas markets.


Founded

1992

HQ

China
Employees

2.7K+

Website

starlake.com.cn

Financials

LTM Revenue n/a

LTM EBITDA n/a

EV

$1.8B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Star Lake Bioscience Financials

Star Lake Bioscience has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.

In the most recent fiscal year, Star Lake Bioscience achieved revenue of $2.4B and an EBITDA of $260M.

Star Lake Bioscience expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Star Lake Bioscience valuation multiples based on analyst estimates

Star Lake Bioscience P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $2.4B $2.4B XXX XXX XXX
Gross Profit $42.2M $425M XXX XXX XXX
Gross Margin 2% 18% XXX XXX XXX
EBITDA $365M $260M XXX XXX XXX
EBITDA Margin 15% 11% XXX XXX XXX
Net Profit $14.7M $83.8M XXX XXX XXX
Net Margin 1% 4% XXX XXX XXX
Net Debt $10.7M $340M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Star Lake Bioscience Stock Performance

As of April 15, 2025, Star Lake Bioscience's stock price is CNY 7 (or $1).

Star Lake Bioscience has current market cap of CNY 11.1B (or $1.5B), and EV of CNY 13.0B (or $1.8B).

See Star Lake Bioscience trading valuation data

Star Lake Bioscience Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$1.8B $1.5B XXX XXX XXX XXX $0.08

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Star Lake Bioscience Valuation Multiples

As of April 15, 2025, Star Lake Bioscience has market cap of $1.5B and EV of $1.8B.

Star Lake Bioscience's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate Star Lake Bioscience's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Star Lake Bioscience and 10K+ public comps

Star Lake Bioscience Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $1.8B XXX XXX XXX
EV/Revenue 0.7x XXX XXX XXX
EV/EBITDA 6.9x XXX XXX XXX
P/E 16.4x XXX XXX XXX
P/E/Growth 0.4x XXX XXX XXX
EV/FCF 7.9x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Star Lake Bioscience Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Star Lake Bioscience Valuation Multiples

Star Lake Bioscience's NTM/LTM revenue growth is n/a

Star Lake Bioscience's revenue per employee for the last fiscal year averaged $0.9M, while opex per employee averaged $0.1M for the same period.

Over next 12 months, Star Lake Bioscience's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Star Lake Bioscience's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Star Lake Bioscience and other 10K+ public comps

Star Lake Bioscience Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth -1% XXX XXX XXX XXX
EBITDA Margin 11% XXX XXX XXX XXX
EBITDA Growth -29% XXX XXX XXX XXX
Rule of 40 (SaaS-only) n/a XXX XXX XXX XXX
Revenue per Employee $0.9M XXX XXX XXX XXX
Opex per Employee $0.1M XXX XXX XXX XXX
S&M Expenses to Revenue 1% XXX XXX XXX XXX
G&A Expenses to Revenue 1% XXX XXX XXX XXX
R&D Expenses to Revenue 1% XXX XXX XXX XXX
Opex to Revenue 7% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Star Lake Bioscience Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics and Small Molecules comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Star Lake Bioscience M&A and Investment Activity

Star Lake Bioscience acquired  XXX companies to date.

Last acquisition by Star Lake Bioscience was  XXXXXXXX, XXXXX XXXXX XXXXXX . Star Lake Bioscience acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Star Lake Bioscience

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Star Lake Bioscience

When was Star Lake Bioscience founded? Star Lake Bioscience was founded in 1992.
Where is Star Lake Bioscience headquartered? Star Lake Bioscience is headquartered in China.
How many employees does Star Lake Bioscience have? As of today, Star Lake Bioscience has 2.7K+ employees.
Is Star Lake Bioscience publicy listed? Yes, Star Lake Bioscience is a public company listed on SHG.
What is the stock symbol of Star Lake Bioscience? Star Lake Bioscience trades under 600866 ticker.
When did Star Lake Bioscience go public? Star Lake Bioscience went public in 1994.
Who are competitors of Star Lake Bioscience? Similar companies to Star Lake Bioscience include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of Star Lake Bioscience? Star Lake Bioscience's current market cap is $1.5B
What is the current revenue growth of Star Lake Bioscience? Star Lake Bioscience revenue growth between 2023 and 2024 was -1%.
Is Star Lake Bioscience profitable? Yes, Star Lake Bioscience is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.